Lexaria Bioscience's total assets for Q2 2026 were $6.49M, an increase of 7.21% from the previous quarter. LEXX total liabilities were $277.00K for the fiscal quarter, a -81.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.